Research ArticleArticle
Molecular Site of Action of the Antiarrhythmic Drug Propafenone at the Voltage-Operated Potassium Channel Kv2.1
Michael Madeja, Thorsten Leicher, Patrick Friederich, Mark A. Punke, Wilhelm Haverkamp, Ulrich Mußhoff, Günter Breithardt and Erwin-Josef Speckmann
Molecular Pharmacology March 2003, 63 (3) 547-556; DOI: https://doi.org/10.1124/mol.63.3.547
Michael Madeja
1
2
3
4
5
Thorsten Leicher
1
2
3
4
5
Patrick Friederich
1
2
3
4
5
Mark A. Punke
1
2
3
4
5
Wilhelm Haverkamp
1
2
3
4
5
Ulrich Mußhoff
1
2
3
4
5
Günter Breithardt
1
2
3
4
5
Erwin-Josef Speckmann
1
2
3
4
5

Submit a Response to This Article
Jump to comment:
No eLetters have been published for this article.
In this issue
Research ArticleArticle
Molecular Site of Action of the Antiarrhythmic Drug Propafenone at the Voltage-Operated Potassium Channel Kv2.1
Michael Madeja, Thorsten Leicher, Patrick Friederich, Mark A. Punke, Wilhelm Haverkamp, Ulrich Mußhoff, Günter Breithardt and Erwin-Josef Speckmann
Molecular Pharmacology March 1, 2003, 63 (3) 547-556; DOI: https://doi.org/10.1124/mol.63.3.547
Research ArticleArticle
Molecular Site of Action of the Antiarrhythmic Drug Propafenone at the Voltage-Operated Potassium Channel Kv2.1
Michael Madeja, Thorsten Leicher, Patrick Friederich, Mark A. Punke, Wilhelm Haverkamp, Ulrich Mußhoff, Günter Breithardt and Erwin-Josef Speckmann
Molecular Pharmacology March 1, 2003, 63 (3) 547-556; DOI: https://doi.org/10.1124/mol.63.3.547
Jump to section
Related Articles
Cited By...
More in this TOC Section
Similar Articles
Advertisement